Clinical trial
Integrative Medicine in Pain Management in Sickle Cell Disease: Assessing the Clinical Efficacy and Neurobiological Impact With Acupuncture, 2.0
NCT06725550 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Integrative Medicine in Pain Management in Sickle Cell Disease: Assessing the Clinical Efficacy and Neurobiological Impact With Acupuncture, 2.0
- Lead sponsor
- University of Cincinnati
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 1, 2026
- Completion date
- June 28, 2031
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acupuncture, circulating biomarkers, electroencephalography, functional near-infrared spectroscopy, magnetic resonance imaging, pain, quantitative sensory testing, sickle cell disease